tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Syndax price target raised to $56 from $43 at BTIG
PremiumThe FlySyndax price target raised to $56 from $43 at BTIG
21d ago
Syndax Pharmaceuticals Reports Strong Q2 2025 Growth
Premium
Company Announcements
Syndax Pharmaceuticals Reports Strong Q2 2025 Growth
21d ago
Syndax Pharmaceuticals: Strong Performance and Growth Potential Justify Buy Rating
Premium
Ratings
Syndax Pharmaceuticals: Strong Performance and Growth Potential Justify Buy Rating
21d ago
Syndax price target lowered to $35 from $37 at UBS
PremiumThe FlySyndax price target lowered to $35 from $37 at UBS
1M ago
3 ‘Strong Buy’ Russell 2000 Stocks with Triple-Digit Upside Potential
Premium
Market News
3 ‘Strong Buy’ Russell 2000 Stocks with Triple-Digit Upside Potential
1M ago
Syndax Pharmaceuticals’ Axatilimab Study: A Potential Breakthrough for IPF Treatment
Premium
Company Announcements
Syndax Pharmaceuticals’ Axatilimab Study: A Potential Breakthrough for IPF Treatment
2M ago
Promising Potential of Syndax Pharmaceuticals’ Revuforj Drives Buy Rating
PremiumRatingsPromising Potential of Syndax Pharmaceuticals’ Revuforj Drives Buy Rating
2M ago
Syndax reports publication of revumenib data from BEAT AML trial
Premium
The Fly
Syndax reports publication of revumenib data from BEAT AML trial
2M ago
Syndax announces new data from AUGMENT-101 trial of Revuforj
Premium
The Fly
Syndax announces new data from AUGMENT-101 trial of Revuforj
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100